HT
TXG icon

Headlands Technologies’s 10x Genomics TXG Stock Holding History

Headlands Technologies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,931
Closed -$374K – 985
2025
Q4 		$374K Buy
22,931
+10,817
+89% +$163K 0.03% 468
2025
Q3 		$142K Buy
+12,114
New +$158K 0.01% 562
2024
Q3 		– Sell
-12
Closed -$233 – 1549
2024
Q2 		$233 Sell
12
-1,880
-99% -$49.2K ﹤0.01% 1078
2024
Q1 		$71K Buy
+1,892
New +$83.1K 0.02% 619
2023
Q4 		– Sell
-523
Closed -$21.6K – 1303
2023
Q3 		$21.6K Sell
523
-4,097
-89% -$213K 0.01% 581
2023
Q2 		$258K Buy
+4,620
New +$250K 0.08% 249

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Headlands Technologies's TXG Position: Q1 2026 in Review

Headlands Technologies sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 22,931 shares — an estimated $374K sold.

Headlands Technologies first reported a position in TXG in Q2 2023 and held it in 6 quarters. The position peaked at $374K in Q4 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Headlands Technologies reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 22,931 10x Genomics shares in Q1 2026, an estimated $374K.
  • Headlands Technologies first reported a position in 10x Genomics in Q2 2023 and held it in 6 quarters.
  • Headlands Technologies's 10x Genomics position peaked at $374K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.